Type Mutant Stock; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Mating System Homozygote x Homozygote (Female x Male) 26-OCT-10 Species laboratory mouse Donating Investigator Tom Gridley, Maine Medical Center Research Institute Description
These mice possess loxP sites on either side of exon 4, which encodes the DSL (Delta-Serrate-Lag2) domain, of the targeted gene. Mice that are homozygous for this allele are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. When these mutant mice are bred to mice that express Cre recombinase, resulting offspring will have exon 4 deleted in the cre-expressing tissue(s). The exon 4-deleted allele produces a nonfunctional JAG1 protein.When bred to a strain with Cre recombinase expression during development in the telencephalon and discrete head structures, such as the otocyst (see Stock No. 006084 for example), this mutant mouse strain may be useful in studies of developmental inner ear defects.
When bred to a strain with Cre recombinase expression in endothelial cells during embryogenesis and adulthood (see Stock No. 004128 for example), this mutant mouse strain may be useful in studies of congenital heart defects and ductus arteriosus development.
When bred to mice carrying Tg(Wnt1-cre)11Rth (Stock No. 009107), Cre recombinase expression in the midbrain and developing neural tube results in a craniofacial phenotype characteristic of Alagille Syndrome.
Development
A FRT site flanked targeting vector containing a PGK-neo cassette was utilized in the construction of this mutant. This selection cassette and a loxP site was inserted downstream of exon 4 of the targeted gene, and another loxP site was inserted upstream of exon 4. This construct was electroporated into 129S1/Sv-Oca2+ Tyr+ Kitl+ derived CJ7 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6J blastocysts. The resulting chimeric male animals were crossed to C57BL/6J females. Heterozygotes were intercrossed to generate homozygotes. The mice were then crossed to 129S4/SvJaeSor-Gt(ROSA)26Sortm1(FLP1)Dym/J (STOCK no. 003946) to remove the PGK-neo selection cassette. These mice no longer carry the Gt(ROSA)26Sortm1(FLP1)Dym allele. The mice were crossed to C57BL/6J once to establish the colony.
| Control | ||
|---|---|---|
| None Available | ||
| Considerations for Choosing Controls | ||
Facebase: models
007664 129S-Efnb1tm1Sor/J 000646 A/J 000647 A/WySnJ 005709 B6.129-Skitm1Cco/J 002619 B6.129-Tgfb3tm1Doe/J 007453 B6.129P2(Cg)-Dhcr7tm1Gst/J 010525 B6.129S-Notch2tm3Grid/J 010616 B6.129S1-Jag1tm1Grid/J 010546 B6.129S1-Jag2tm1Grid/J 010620 B6.129S1-Notch2tm1Grid/J 009387 B6.129S1-Osr1tm1Jian/J 009386 B6.129S1-Osr2tm1Jian/J 010621 B6.129S1-Snai1tm2.1Grid/J 010617 B6.129S1-Snai2tm1Grid/J 003865 B6.129S2-Itgavtm1Hyn/J 003755 B6.129S4-Meox2tm1(cre)Sor/J 016902 B6.129S5-Irf6Gt(OST398253)Lex/J 003336 B6.129S7-Cdkn1ctm1Sje/J 012843 B6.129X1(Cg)-Slc32a1tm1.1Bgc/J 000026 B6.C3-Gli3Xt-J/J 004275 B6.Cg-Fignfi/Frk 012844 B6.Cg-Gad1tm1.1Bgc/J 006382 B6;129-Casktm1Sud/J 002711 B6;129-Gabrb3tm1Geh/J 004293 B6;129-Shhtm2Amc/J 012603 B6;129-Tgfbr2tm1Karl/J 010686 B6;129S-Snai1tm2Grid/J 009389 B6;129S1-Bambitm1Jian/J 010619 B6;129S1-Lfngtm1Grid/J 010547 B6;129S1-Notch3tm1Grid/J 010544 B6;129S1-Notch4tm1Grid/J 010722 B6;129S1-Snai2tm2Grid/J 012463 B6;129S4-Foxd1tm1(GFP/cre)Amc/J 003277 B6;129S7-Acvr2atm1Zuk/J 002788 B6;129S7-Fsttm1Zuk/J 002990 B6;129S7-Inhbatm1Zuk/J 000523 B6By.Cg-Eh/J 000278 B6C3Fe a/a-Papss2bm Hps1ep Hps6ru/J 000515 B6CBACa Aw-J/A-SfnEr/J 001434 C3HeB/FeJ x STX/Le-Mc1rE-so Gli3Xt-J Zeb1Tw/J 000252 DC/LeJ 005057 FVB.129-Kcnj2tm1Swz/J 012655 FVB.A-Irf6clft1/BeiJ 013100 FVB.C-Prdm16csp1/J 017437 FVB/N-Ckap5TgTn(sb-cHS4,Tyr)2320F-1Ove/J 017438 FVB/N-MidnTg(Tyr)2261EOve/J 017609 FVB/N-Rr16Tn(sb-Tyr)1HCebOve/J 017598 FVB/N-Sdccag8Tn(sb-Tyr)2161B.CA1C2Ove/J 017608 FVB/N-Skor2Tn(sb-Tyr)1799B.CA7BOve/J 017436 FVB/N-Tapt1TgTn(sb-cHS4,Tyr)2508GOve/J 016870 FVB/NJ-Ap2b1Tg(Tyr)427Ove/EtevJ 017434 FVB;B6-Cramp1lTgTn(sb-rtTA,Tyr)2447AOve/J 017594 FVB;B6-Eya4TgTn(Prm1-sb10,sb-Tyr)1739AOve/J 017435 FVB;B6-SlmapTn(sb-rtTA)2426B.SB4Ove/J 003318 STOCK Shhtm1Amc/J 003102 STOCK Tgfb2tm1Doe/J 018624 STOCK Tgfb3tm2(Tgfb1)Vk/J 008469 STOCK Wnt9btm1.2Amc/J View Facebase: models (58 strains)
Strains carrying other alleles of Jag1
010616 B6.129S1-Jag1tm1Grid/J View Strains carrying other alleles of Jag1 (1 strain)
Introduction to Cre-lox technology
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms provided by MGI
- Model with phenotypic similarity to human disease where etiologies involve orthologs. Human genes are associated with this disease. Orthologs of those genes appear in the mouse genotype(s).
Alagille Syndrome 1; ALGS1
- Potential model based on gene homology relationships. Phenotypic similarity to the human disease has not been tested. Jagged 1; JAG1 (JAG1)
Tetralogy of Fallot; TOF (JAG1)
View Mammalian Phenotype Terms
Mammalian Phenotype Terms provided by MGI
assigned by genotype
The following phenotype relates to a compound genotype created using this strain.
Contact JAX® Services jaxservices@jax.org for customized breeding options.Jag1tm2Grid/Jag1tm2Grid Tg(Tek-cre)12Flv/0
involves: C3H * C57BL/6 (conditional)
- mortality/aging
- complete embryonic lethality during organogenesis
- die at approximately E10.5 (MGI Ref ID J:166769)
- cardiovascular system phenotype
- abnormal vascular smooth muscle morphology
- non-cell autonomous defects in vascular smooth muscle cell differentiation (MGI Ref ID J:166769)
- abnormal vitelline vascular remodeling
- fail to remodel the primary vascular plexus of the yolk sac to form large blood vessels (MGI Ref ID J:166769)
- hemorrhage (MGI Ref ID J:166769)
- pericardial edema (MGI Ref ID J:166769)
- embryogenesis phenotype
- abnormal vitelline vascular remodeling
- fail to remodel the primary vascular plexus of the yolk sac to form large blood vessels (MGI Ref ID J:166769)
- homeostasis/metabolism phenotype
- pericardial edema (MGI Ref ID J:166769)
- muscle phenotype
- abnormal vascular smooth muscle morphology
- non-cell autonomous defects in vascular smooth muscle cell differentiation (MGI Ref ID J:166769)
Jag1tm2Grid/Jag1tm2Grid Tg(Wnt1-cre)11Rth/0
involves: 129S1/Sv * C57BL/6 * CBA (conditional)
- mortality/aging
- premature death
- maxilla deficiencies lead to poor feeding and death around one month of age (MGI Ref ID J:181120)
- growth/size phenotype
- decreased body size (MGI Ref ID J:181120)
- craniofacial phenotype
- abnormal palate morphology
- the palatal dimensions are proportionally smaller, however the structural components are in tact (MGI Ref ID J:181120)
- mutants exhibit reduced proliferation in the palate shelves at E14.5 and in the adjacent palatal epithelium (MGI Ref ID J:181120)
- mutants exhibit reduced hyaluronic acid in the palate shelves at E14.5 (MGI Ref ID J:181120)
- mutants exhibit aberrant vascular pattering in the palate including reduced vascular branching at E14.5 and E15.5 (MGI Ref ID J:181120)
- abnormal primary palate development
- at E14.5, palatal shelf elevation above the tongue occurs normally but palatal elongation is reduced anteriorly, whereas the posterior palate shelf length is unaffected (MGI Ref ID J:181120)
- mutants exhibit delayed palatal shelf elongation (MGI Ref ID J:181120)
- some E15.5 mutants show delayed palate shelf apposition and the persistence of the epithelial seam, however palate fusion occurs in all mutants (MGI Ref ID J:181120)
- short palate
- palate shelf height is reduced in both the anterior and posterior regions (MGI Ref ID J:181120)
- malocclusion
- dental occlusion is misaligned with severe midface hypoplasia requiring trimming of the lower incisors weekly (MGI Ref ID J:181120)
- midface retrusion
- midfacial hypoplasia resulting in a reduction in anterior facial width (MGI Ref ID J:181120)
- short maxilla
- skeleton phenotype
- malocclusion
- dental occlusion is misaligned with severe midface hypoplasia requiring trimming of the lower incisors weekly (MGI Ref ID J:181120)
- short maxilla
- behavior/neurological phenotype
- decreased eating behavior
- mutants exhibit poor feeding after 30 days of age due to malocclusion and require soft mouse chow (MGI Ref ID J:181120)
- cardiovascular system phenotype
- abnormal blood vessel morphology
- mutants exhibit aberrant vascular pattering in the palate; reduced vascular branching in the palate at E14.5 and E15.5, reduced vasculature organization and vessel size, poor vascular smooth muscle investment, and irregular vessel formation (MGI Ref ID J:181120)
- digestive/alimentary phenotype
- abnormal palate morphology
- the palatal dimensions are proportionally smaller, however the structural components are in tact (MGI Ref ID J:181120)
- mutants exhibit reduced proliferation in the palate shelves at E14.5 and in the adjacent palatal epithelium (MGI Ref ID J:181120)
- mutants exhibit reduced hyaluronic acid in the palate shelves at E14.5 (MGI Ref ID J:181120)
- mutants exhibit aberrant vascular pattering in the palate including reduced vascular branching at E14.5 and E15.5 (MGI Ref ID J:181120)
- abnormal primary palate development
- at E14.5, palatal shelf elevation above the tongue occurs normally but palatal elongation is reduced anteriorly, whereas the posterior palate shelf length is unaffected (MGI Ref ID J:181120)
- mutants exhibit delayed palatal shelf elongation (MGI Ref ID J:181120)
- some E15.5 mutants show delayed palate shelf apposition and the persistence of the epithelial seam, however palate fusion occurs in all mutants (MGI Ref ID J:181120)
- short palate
- palate shelf height is reduced in both the anterior and posterior regions (MGI Ref ID J:181120)
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Research Tools
Cre-lox System
loxP-flanked Sequences
Developmental Biology Research
Cre-lox System
| Allele Symbol | Jag1tm2Grid | ||
|---|---|---|---|
| Allele Name | targeted mutation 2, Tom Gridley | ||
| Allele Type | Targeted (Floxed/Frt) | ||
| Common Name(s) | Jag1flox; | ||
| Mutation Made By | Tom Gridley, Maine Medical Center Research Institute | ||
| Strain of Origin | 129S1/Sv-Oca2<+> Tyr<+> Kitl<+> | ||
| Gene Symbol and Name | Jag1, jagged 1 | ||
| Chromosome | 2 | ||
| Gene Common Name(s) | ABE2; AGS; AHD; AWS; CD339; Gsfabe2; HJ1; Headturner; Htu; JAGL1; Ozz; Serrate-1; gsf abnormal behavior 2; headturner; ozzy; | ||
| Molecular Note | Exon 4 was flanked by loxP sites. An FRT-flanked neo was removed from the locus. [MGI Ref ID J:115783] | ||
Genotyping Protocols
Jag1tm2Grid, Standard PCR
Helpful Links
Genotyping resources and troubleshooting
Kiernan AE; Xu J; Gridley T. 2006. The Notch ligand JAG1 is required for sensory progenitor development in the mammalian inner ear. PLoS Genet 2(1):e4. [PubMed: 16410827] [MGI Ref ID J:115783]
Jag1tm2Grid relatedFeng X; Krebs LT; Gridley T. 2010. Patent ductus arteriosus in mice with smooth muscle-specific Jag1 deletion. Development 137(24):4191-9. [PubMed: 21068062] [MGI Ref ID J:166769]
High FA; Jain R; Stoller JZ; Antonucci NB; Lu MM; Loomes KM; Kaestner KH; Pear WS; Epstein JA. 2009. Murine Jagged1/Notch signaling in the second heart field orchestrates Fgf8 expression and tissue-tissue interactions during outflow tract development. J Clin Invest 119(7):1986-96. [PubMed: 19509466] [MGI Ref ID J:152574]
High FA; Lu MM; Pear WS; Loomes KM; Kaestner KH; Epstein JA. 2008. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc Natl Acad Sci U S A 105(6):1955-9. [PubMed: 18245384] [MGI Ref ID J:143962]
Humphreys R; Zheng W; Prince LS; Qu X; Brown C; Loomes K; Huppert SS; Baldwin S; Goudy S. 2012. Cranial neural crest ablation of Jagged1 recapitulates the craniofacial phenotype of Alagille syndrome patients. Hum Mol Genet 21(6):1374-83. [PubMed: 22156581] [MGI Ref ID J:181120]
Pan W; Jin Y; Stanger B; Kiernan AE. 2010. Notch signaling is required for the generation of hair cells and supporting cells in the mammalian inner ear. Proc Natl Acad Sci U S A 107(36):15798-803. [PubMed: 20733081] [MGI Ref ID J:164383]
Animal Health Reports
Room Number AX11
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, these mice can be bred as homozygotes. Mating System Homozygote x Homozygote (Female x Male) 26-OCT-10 Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Price per mouse (US dollars $) Gender Genotypes Provided Individual Mouse $195.00 Female or Male Homozygous for Jag1tm2Grid
Price per Pair (US dollars $) Pair Genotype $390.00 Homozygous for Jag1tm2Grid x Homozygous for Jag1tm2Grid Standard Supply
Repository-Live.
Repository-Live represents an exclusive set of over 1500 unique mouse models across a vast array of research areas. Breeding colonies provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. If a Repository strain is not immediately available, then within 2 to 3 business days, you will receive an estimated availability timeframe for your inquiry or order along with various delivery options. Repository strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping. We will note and try to accommodate requests for specific ages of Repository strains but cannot guarantee provision of these strains at specific ages. However, if cohorts of mice (5 or more of one gender) are needed at a specific age range for experiments, please let us know.
| Pricing for International shipping destinations |
|
Price per mouse (US dollars $) Gender Genotypes Provided Individual Mouse $253.50 Female or Male Homozygous for Jag1tm2Grid
Price per Pair (US dollars $) Pair Genotype $507.00 Homozygous for Jag1tm2Grid x Homozygous for Jag1tm2Grid Standard Supply
Repository-Live.
Repository-Live represents an exclusive set of over 1500 unique mouse models across a vast array of research areas. Breeding colonies provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. If a Repository strain is not immediately available, then within 2 to 3 business days, you will receive an estimated availability timeframe for your inquiry or order along with various delivery options. Repository strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping. We will note and try to accommodate requests for specific ages of Repository strains but cannot guarantee provision of these strains at specific ages. However, if cohorts of mice (5 or more of one gender) are needed at a specific age range for experiments, please let us know.
|
|
Repository-Live.
Repository-Live represents an exclusive set of over 1500 unique mouse models across a vast array of research areas. Breeding colonies provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. If a Repository strain is not immediately available, then within 2 to 3 business days, you will receive an estimated availability timeframe for your inquiry or order along with various delivery options. Repository strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping. We will note and try to accommodate requests for specific ages of Repository strains but cannot guarantee provision of these strains at specific ages. However, if cohorts of mice (5 or more of one gender) are needed at a specific age range for experiments, please let us know.
| Control | ||
|---|---|---|
| None Available | ||
| Considerations for Choosing Controls | ||
| Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.